168 related articles for article (PubMed ID: 34737982)
1. Analysis of Ureteral Tumour Stents for Malignant Ureteral Obstruction: Towards Reshaping an Optimal Stent.
Vogt B; Blanchet LH
Res Rep Urol; 2021; 13():773-782. PubMed ID: 34737982
[TBL] [Abstract][Full Text] [Related]
2. 10-Year Experience with Reinforced Ureteral Stents for Malignant Ureteral Obstruction.
Vogt B; Blanchet LH
Res Rep Urol; 2021; 13():581-589. PubMed ID: 34430510
[TBL] [Abstract][Full Text] [Related]
3. Stiffness Analysis of Reinforced Ureteral Stents Against Radial Compression: In vitro Study.
Vogt B
Res Rep Urol; 2020; 12():583-591. PubMed ID: 33274188
[TBL] [Abstract][Full Text] [Related]
4. It is Possible to Reduce Ureteral Stent Clogging and Stent-Related Symptoms to Soothe the Pain of the Patient: A Case Report.
Vogt B; Dove-Rumé J
Res Rep Urol; 2023; 15():315-319. PubMed ID: 37425651
[TBL] [Abstract][Full Text] [Related]
5. Tandem ureteral stents drainage lowers renal pelvis pressure in malignant ureteral obstruction: Experimental and computational models.
Haifler M; Kleinmann N; Weiss D
J Biomech; 2021 Mar; 117():110237. PubMed ID: 33486265
[TBL] [Abstract][Full Text] [Related]
6. Tandem ureteral stents for the decompression of malignant and benign obstructive uropathy.
Elsamra SE; Motato H; Moreira DM; Waingankar N; Friedlander JI; Weiss G; Smith AD; Okeke Z
J Endourol; 2013 Oct; 27(10):1297-302. PubMed ID: 23829600
[TBL] [Abstract][Full Text] [Related]
7. Factors Associated with Ureteral Stent Failure in Patients with Malignant Ureteral Obstruction.
Pickersgill NA; Wahba BM; Vetter JM; Cope SJ; Barashi NS; Henning GM; Du K; Figenshau RS; Desai AC; Venkatesh R
J Endourol; 2022 Jun; 36(6):814-818. PubMed ID: 35018790
[No Abstract] [Full Text] [Related]
8. Risk factors in the prediction of long-term patency of Resonance metallic ureteric stent in malignant ureteric obstruction.
Ho BSH; Chiu PKF; Lam W; Wong JHF; Wong CKW; Lai TCT; Tsang CF; Ng ATL; Chan CK; Ma WK; Ng CF; Tsu JHL
BJUI Compass; 2020 May; 1(2):74-81. PubMed ID: 35474710
[TBL] [Abstract][Full Text] [Related]
9. Influence of Single Stent Size and Tandem Stents Subject to Extrinsic Ureteral Obstruction and Stent Occlusion on Stent Failure.
Amitay-Rosen T; Shilo Y; Dror I; Berkowitz B
J Endourol; 2022 Feb; 36(2):236-242. PubMed ID: 34314233
[No Abstract] [Full Text] [Related]
10. Comparison of single and tandem ureteral stenting for malignant ureteral obstruction: a prospective study of 104 patients.
Liu KL; Lee BC; Ye JD; Chang YH; Chang CC; Huang KH; Lee YJ; Chang YC
Eur Radiol; 2019 Feb; 29(2):628-635. PubMed ID: 29974220
[TBL] [Abstract][Full Text] [Related]
11. Application of resonance metallic stents for malignant ureteral obstruction.
Kang Q; Jiang F; Yu Y; Shen C; Lv H; Yang B
Minim Invasive Ther Allied Technol; 2018 Dec; 27(6):333-338. PubMed ID: 29475395
[No Abstract] [Full Text] [Related]
12. Use of full-length metallic stents in malignant ureteral obstruction.
Abbasi A; Wyre HW; Ogan K
J Endourol; 2013 May; 27(5):640-5. PubMed ID: 23237309
[TBL] [Abstract][Full Text] [Related]
13. Unveiling the Challenges in Tandem Ureteral Stent Management for Malignant Ureteral Obstruction: Failure Rate, Risk Factors, and Durability of Their Replacement.
Carmona O; Shvero A; Zilberman DE; Dotan ZA; Kleinmann N
J Clin Med; 2023 Aug; 12(16):. PubMed ID: 37629293
[TBL] [Abstract][Full Text] [Related]
14. Investigating the encrustation of reinforced ureteral stents by computational flow dynamic simulations.
Vogt B
World J Urol; 2023 May; 41(5):1451-1457. PubMed ID: 36930252
[TBL] [Abstract][Full Text] [Related]
15. Tandem ureteral stents in the management of double-J stent dysfunction in gynecological malignancies.
Ozyer U; Dirim A
Diagn Interv Imaging; 2017 Sep; 98(9):601-608. PubMed ID: 28802719
[TBL] [Abstract][Full Text] [Related]
16. [The Predictive Factors of Stent Failure in the Treatment of Malignant Extrinsc Ureteral Obstruction Using Internal Ureteral Stents].
Matsuura H; Arase S; Hori Y; Tochigi H
Hinyokika Kiyo; 2017 Dec; 63(12):503-507. PubMed ID: 29370660
[TBL] [Abstract][Full Text] [Related]
17. Use of metallic and polymeric ureteral stents in malignant ureteral obstruction.
Ohtaka M; Kawahara T; Hayashi Y; Kobayashi R; Tsutsumi S; Ousaka K; Takizawa A; Kishida T; Yao M; Uemura H
BJUI Compass; 2021 Jan; 2(1):58-63. PubMed ID: 35474665
[TBL] [Abstract][Full Text] [Related]
18. Stenting for malignant ureteral obstruction: Tandem, metal or metal-mesh stents.
Elsamra SE; Leavitt DA; Motato HA; Friedlander JI; Siev M; Keheila M; Hoenig DM; Smith AD; Okeke Z
Int J Urol; 2015 Jul; 22(7):629-36. PubMed ID: 25950837
[TBL] [Abstract][Full Text] [Related]
19. Ureteral stents for malignant extrinsic ureteral obstruction: outcomes and factors predicting stent failure.
Matsuura H; Arase S; Hori Y
Int J Clin Oncol; 2019 Mar; 24(3):306-312. PubMed ID: 30298199
[TBL] [Abstract][Full Text] [Related]
20. Gastrointestinal cancer and bilateral hydronephrosis resulted in a high risk of ureteral stent failure.
Ohtaka M; Kawahara T; Takamoto D; Mochizuki T; Hattori Y; Teranishi JI; Makiyama K; Miyoshi Y; Yumura Y; Yao M; Uemura H
BMC Urol; 2018 May; 18(1):35. PubMed ID: 29739370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
